ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Estrella Immunopharma Inc

Estrella Immunopharma Inc (ESLA)

1.18
-0.01
(-0.84%)
Closed January 13 3:00PM
1.18
0.00
(0.00%)
After Hours: 4:12PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.18
Bid
1.06
Ask
1.29
Volume
5,936
1.17 Day's Range 1.22
0.63 52 Week Range 3.23
Market Cap
Previous Close
1.19
Open
1.17
Last Trade
3
@
1.15
Last Trade Time
Financial Volume
US$ 7,021
VWAP
1.1828
Average Volume (3m)
31,902
Shares Outstanding
36,179,147
Dividend Yield
-
PE Ratio
-5.84
Earnings Per Share (EPS)
-0.2
Revenue
-
Net Profit
-7.31M

About Estrella Immunopharma Inc

TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Estrella Immunopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ESLA. The last closing price for Estrella Immunopharma was US$1.19. Over the last year, Estrella Immunopharma shares have traded in a share price range of US$ 0.63 to US$ 3.23.

Estrella Immunopharma currently has 36,179,147 shares outstanding. The market capitalization of Estrella Immunopharma is US$43.05 million. Estrella Immunopharma has a price to earnings ratio (PE ratio) of -5.84.

ESLA Latest News

Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat...

Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) ("Estrella", “Estrella Immunopharma”, or the "Company"), a clinical stage biopharmaceutical company focused on developing CD19 and CD22-targeted...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.07-5.61.251.251.02155371.17396227CS
4001.181.411.02262831.20979235CS
120.334.09090909090.881.4850.63319021.16375709CS
26-0.22-15.71428571431.43.230.631170391.48213622CS
52-0.05-4.065040650411.233.230.63739551.40857465CS
156-4.03-77.35124760085.215.620.63753261.55659776CS
260-4.03-77.35124760085.215.620.63753261.55659776CS

ESLA - Frequently Asked Questions (FAQ)

What is the current Estrella Immunopharma share price?
The current share price of Estrella Immunopharma is US$ 1.18
How many Estrella Immunopharma shares are in issue?
Estrella Immunopharma has 36,179,147 shares in issue
What is the market cap of Estrella Immunopharma?
The market capitalisation of Estrella Immunopharma is USD 43.05M
What is the 1 year trading range for Estrella Immunopharma share price?
Estrella Immunopharma has traded in the range of US$ 0.63 to US$ 3.23 during the past year
What is the PE ratio of Estrella Immunopharma?
The price to earnings ratio of Estrella Immunopharma is -5.84
What is the reporting currency for Estrella Immunopharma?
Estrella Immunopharma reports financial results in USD
What is the latest annual profit for Estrella Immunopharma?
The latest annual profit of Estrella Immunopharma is USD -7.31M
What is the registered address of Estrella Immunopharma?
The registered address for Estrella Immunopharma is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
Which industry sector does Estrella Immunopharma operate in?
Estrella Immunopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PHIOPhio Pharmaceuticals Corporation
US$ 6.50
(284.62%)
281.98M
SLRXSalarius Pharmaceuticals Inc
US$ 3.65
(133.23%)
120.26M
VRMEVerifyMe Inc
US$ 4.1575
(63.04%)
57.6M
ATPCAgape ATP Corporation
US$ 1.9645
(55.91%)
84.16M
AVGRAvinger Inc
US$ 0.8248
(46.47%)
9.78M
EHGOEshallgo Inc
US$ 1.2408
(-62.06%)
6.74M
CMTLComtech Telecommunications Corporation
US$ 2.3491
(-43.12%)
4.37M
SVMHSRIVARU Holding Ltd
US$ 0.0352
(-43.04%)
184.27M
LAESSEALSQ Corporation
US$ 3.35
(-41.54%)
89.92M
NMHINatures Miracle Holding Inc
US$ 1.12
(-38.80%)
735.08k
GCTKGlucoTrack Inc
US$ 0.1493
(27.61%)
685.02M
PHIOPhio Pharmaceuticals Corporation
US$ 6.50
(284.62%)
281.98M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0627
(-28.83%)
232.25M
NVDANVIDIA Corporation
US$ 133.23
(-1.97%)
204.68M
RGTIRigetti Computing Inc
US$ 6.0344
(-32.43%)
192.21M